Evidence map›Paper›PMID 39230749›Full record

ArticleAnalytical and bioanalytical chemistry2024

Monomer-mediated growth of β-cyclodextrin-based microporous organic network as stationary phase for capillary electrochromatography.

Zhengzheng Liao, Jinfang Hu, Zhentao Li

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhengzheng LiaoDepartment of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006, Nanchang, Jiangxi, People's Republic of China.
Jinfang HuDepartment of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006, Nanchang, Jiangxi, People's Republic of China. hujinfang333@126.com.
Zhentao LiDepartment of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006, Nanchang, Jiangxi, People's Republic of China. 1046237778@qq.com.ORCID http://orcid.org/0000-0003-1839-3765

Funding

The Foundation of the Jiangxi Provincial Department of Science and Technology Youth Project 20212BAB216042The Research and Cultivation Project for Young of the First Affiliated Hospital of Nanchang University YFYPY202238
6 · The paper itself

Abstract

CD-MONs (β-cyclodextrin-based microporous organic networks), derived from β-cyclodextrin, possess notable hydrophobic characteristics, a considerable specific surface area, and remarkable stability, rendering them highly advantageous in separation science. This research aimed to investigate the utility of CD-MONs in chromatography separation. Through a monomer-mediated technique, we fabricated an innovative CD-MON modified capillary column for application in open-tubular capillary electrochromatography (OT-CEC). The CD-MON-based stationary phase on the capillary's inner surface was analyzed using Fourier transform infrared (FT-IR) spectroscopy and scanning electron microscopy (SEM). We assessed the performance of the CD-MON modified capillary column for separation purposes. The microstructure and pronounced hydrophobicity of CD-MON contributed to enhanced selectivity and resolution in separating diverse hydrophobic analytes, such as alkylbenzenes, halogenated benzenes, parabens, and polycyclic aromatic hydrocarbons (PAHs). The maximum column efficiency achieved was 1.5 × 10

Indexed as

Capillary electrochromatographyMicroporous organic networksMonomer-mediated approachStationary phaseβ-Cyclodextrin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.